Cadrenal Therapeutics, Inc. (CVKD)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Nov 06, 10:01
Cadrenal Therapeutics Market Cap : 3.192M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 3.099M |
| November 04, 2026 | 3.284M |
| November 03, 2026 | 3.501M |
| November 02, 2026 | 3.222M |
| October 30, 2026 | 3.052M |
| October 29, 2026 | 2.923M |
| October 28, 2026 | 2.937M |
| October 27, 2026 | 2.920M |
| October 26, 2026 | 2.820M |
| October 23, 2026 | 2.975M |
| October 22, 2026 | 3.006M |
| October 21, 2026 | 3.161M |
| October 20, 2026 | 3.222M |
| October 19, 2026 | 3.284M |
| October 16, 2026 | 3.378M |
| October 15, 2026 | 3.006M |
| October 14, 2026 | 3.161M |
| October 13, 2026 | 3.089M |
| October 12, 2026 | 2.703M |
| October 09, 2026 | 2.82M |
| October 08, 2026 | 2.880M |
| October 07, 2026 | 3.013M |
| October 06, 2026 | 3.068M |
| October 05, 2026 | 2.931M |
| October 02, 2026 | 2.913M |
| Date | Value |
|---|---|
| October 01, 2026 | 3.006M |
| September 30, 2026 | 3.346M |
| September 29, 2026 | 3.378M |
| September 28, 2026 | 3.470M |
| September 25, 2026 | 3.563M |
| September 24, 2026 | 3.718M |
| September 23, 2026 | 4.090M |
| September 22, 2026 | 3.470M |
| September 21, 2026 | 3.378M |
| September 18, 2026 | 3.316M |
| September 17, 2026 | 3.470M |
| September 16, 2026 | 3.346M |
| September 15, 2026 | 3.254M |
| September 14, 2026 | 3.284M |
| September 11, 2026 | 3.378M |
| September 10, 2026 | 3.656M |
| September 09, 2026 | 3.687M |
| September 08, 2026 | 3.718M |
| September 04, 2026 | 3.780M |
| September 03, 2026 | 3.966M |
| September 02, 2026 | 4.121M |
| September 01, 2026 | 4.679M |
| August 31, 2026 | 5.422M |
| August 28, 2026 | 4.772M |
| August 27, 2026 | 4.849M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.624B |
| Corcept Therapeutics, Inc. | 8.115B |
| Veru, Inc. | 35.29M |
| Johnson & Johnson | 653.44B |
| Eli Lilly & Co. | 1.291T |
Market Cap Related Metrics
| Price to Book Value | 0.7800 |
| Price | 1.03 |
| Earnings Yield | -476.0% |